Coppell Advisory Solutions Corp. Abb Vie Inc. Transaction History
Coppell Advisory Solutions Corp.
- $531 Billion
- Q1 2024
A detailed history of Coppell Advisory Solutions Corp. transactions in Abb Vie Inc. stock. As of the latest transaction made, Coppell Advisory Solutions Corp. holds 1,212 shares of ABBV stock, worth $207,361. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,212
Previous 1,639
26.05%
Holding current value
$207,361
Previous $259 Million
14.76%
% of portfolio
0.04%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
3,808Shares Held
1.27BCall Options Held
13MPut Options Held
9.94M-
Vanguard Group Inc Valley Forge, PA171MShares$29.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$13.3 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.92 Billion0.84% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$6.6 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $303B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...